Merck & Co (MRK) Stock Price, Quote, News & History | Benzinga

Merck & Co Inc (MRK) Stock Price, Quote, News & History

MRKNYSE

Trade with Public

Trade with Public

$128.66

3.212.56%

At close: Jun 25, 5:00 PM EST

$128.20

2.752.19%

Pre-Market: 9:04 AM EST

OverviewNews Earnings Events Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

$128.66

Volume / Avg.

17.16K / 10.24M

Day Range

- - -

52 Wk Range

76.66 - 128.78

Market Cap

$316.63B

P/E Ratio

36.24

Dividend Yield

2.64%

Exchange

NYSE

RSI

67

Short Interest

1.23%

Days to Cover

2.57

Recent Merck & Co Inc News

Gilead's Trodelvy Expands Reach With New FDA Approval In Breast Cancer

FDA approves Gilead's Trodelvy for first-line metastatic triple-negative breast cancer, expanding use alone and with Keytruda.

Vandana Singh

Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy

Merck reported positive Phase 3 data for tulisokibart in ulcerative colitis, meeting primary and key secondary endpoints.

Vandana Singh

Merck Reports Topline Results From Phase 3 ATLAS-UC Induction-Only Study Evaluating Tulisokibart

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 ATLAS-UC induction-only study (Study 2) evaluating tulisokibart (MK-7240), an

Benzinga News-desk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

17.89B

Investing Cash Flow (TTM)

-22.46B

Financing Cash Flow (TTM)

852.00M

Free Cash Flow (TTM)

14.12B

Capital Expenditure (TTM)

-3.78B

Net Change in Cash (TTM)

-3.72B

Analyst Trends and Forecast

2

1

Mar

2

Apr

1

1

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$361.18B

PE Ratio (TTM)

36.24

PE Ratio (FWD)

25.45

PEG Ratio (TTM)

6.36

PS Ratio (TTM)

4.88

PB Ratio (TTM)

6.93

Earnings Yield % (TTM)

2.76%

Earnings Yield % (FWD)

3.93%

EV / EBITDA (TTM)

18.61

Price / EBITDA (TTM)

16.53

Price / Free Cash Flow (TTM)

22.72

Book Value / Share

$18.58

Company Debt

Total Debt

$49.12B

LT Debt

$46.67B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.14B

Total Cash

$5.33B

Debt to Equity

1.07

Issuance of Debt (TTM)

$12.74B

Repayment of Debt (TTM)

-$1.14B

Key Statistics

Open

-

Close

$128.66

Volume / Avg.

17.16K / 10.24M

Day Range

- - -

52 Wk Range

76.66 - 128.78

Market Cap

$316.63B

P/E Ratio

36.24

Dividend Yield

2.64%

Exchange

NYSE

RSI

67

Short Interest

1.23%

Days to Cover

2.57

About

Sector

Health Care

Industry

Pharmaceuticals

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor t...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Merck & Co (MRK) stock?

A

You can purchase shares of Merck & Co (NYSE:MRK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Merck & Co (MRK) competitors?

A

There are no as such competitors for Merck & Co.

Q

What is the forecast, or price target, for Merck & Co (MRK) stock?

A

Merck & Co has a consensus price target of $125.43.

Q

What is the current price for Merck & Co (MRK)?

A

The stock price for Merck & Co (NYSE: MRK) is $128.2 last updated June 29, 2026 at 9:05 AM EDT.

Q

Does Merck & Co (MRK) pay a dividend?

A

There are no upcoming dividends for Merck & Co.

Q

When is Merck & Co (NYSE:MRK) reporting earnings?

A

Merck & Co does not have any upcoming earnings scheduled.

Q

Is Merck & Co (MRK) going to split?

A

There is no upcoming split for Merck & Co.

Q

What sector and industry does Merck & Co (MRK) operate in?

A

Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.